First Albany Upgrades Trimeris to Buy

Analyst David Webber sees higher sales of the drug maker's AIDS treatment in 2004

First Albany upgraded Trimeris (TRMS ) to buy from neutral.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.